Friday 31 October 2008

Brokers bullish on SBI, Cairn India, Glaxo Pharma

Goldman Sachs has kept sell rating on ONGC, with price target Rs 625

Sharekhan has kept buy rating on SBI, with price target Rs 1801

CLSA has kept buy rating on SBI, with price target Rs 1650

CLSA has kept buy rating on Cairn India, with price target Rs 290

Motilal Oswal Sec has kept buy rating on Glaxo Pharma, with price target Rs 1392

Motilal Oswal Sec has kept buy rating on ICICI Bank, with price target Rs 581

Kotak Institution has kept reduce on NTPC, with price target Rs 160

Kotak Institution has upgraded SBI to buy rating, with price target Rs 1600

Kotak Institution has kept buy rating on Tata Power, with price target Rs 1275

Emkay has kept buy rating on Bank Of India, with price target Rs 340

Citi has kept sell rating on Tata Tele, with price target Rs 12

Citi has kept buy rating on M&M, with price target Rs 447

Source: Moneycontrol

No comments:

Post a Comment

DISCLAIMER: The author is not a registered stockbroker nor a registered advisor and does not give investment advice. His comments are an expression of opinion only and should not be construed in any manner whatsoever as recommendations to buy or sell a stock, option, future, bond, commodity, index or any other financial instrument at any time. While he believes his statements to be true, they always depend on the reliability of his own credible sources. The author recommends that you consult with a qualified investment advisor, one licensed by appropriate regulatory agencies in your legal jurisdiction, before making any investment decisions, and that you confirm the facts on your own before making important investment commitments.